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Abstract
Phosphatidylinositol 3-kinase (PI3K)/Akt signalling pathway can support the replication of influenza A virus through
binding of viral NS1 protein to the Src homology 3 (SH3) domain of p85b regulatory subunit of PI3K. Here we
investigated the effect of heterologously overexpressed SH3 on the replication of different influenza A virus sub-
types/strains, and on the phosphorylation of Akt in the virus-infected cells. We found that heterologous SH3
reduced replication of influenza A viruses at varying degrees in a subtype/strain-dependent manner and SH3 over-
expression reduced the induction of the phosphorylation of Akt in the cells infected with PR8(H1N1) and ST364
(H3N2), but not with ST1233(H1N1), Ph2246(H9N2), and Qa199(H9N2). Our results suggest that interference with
the NS1-p85b interaction by heterologous SH3 can be served as a useful antiviral strategy against influenza A virus
infection.
Background
Influenza A viruses are globally important human and
animal respiratory pathogens, and viral infections cause
highly contagious respiratory diseases. Influenza A virus
can be divided into numerous subtypes (H1~H16 and
N1~N9) according to the antigenicity of hemagglutinin
(HA) and neuraminidase (NA). Among them, H1N1 and
H3N2 subtypes are the most common subtype in
human influenza infections [1]. However, in some situa-
tions, several avian influenza virus subtypes (such as
H5N1, H7N7, or H9N2) can break through the species
barrier and be transmitted to humans [2]. These avian
influenza viruses have posed serious threat to public
health.
One of the main research emphases in the influenza A
virus is its NS1 protein. NS1 can modulate virus infec-
tion and host cell signalling pathway [3-6], such as
phosphatidylinositol 3-kinase(PI3K)/Akt pathway [7].
The PI3K/Akt pathway plays a central role in modulat-
ing diverse downstream signalling pathways associated
with cell survival, proliferation, migration, and differen-
tiation [8-10].
PI3K is a dimeric enzyme consisting of a p110 cata-
lytic subunit (a, b, or δ) tethered to a smaller, non-
catalytic, regulatory subunit p85 (usually p85a, p85b,
p55g, p55a, or p50a) [11-13]. NS1 can interact with
p85b of PI3K via direct binding to SH3 domain of
p85b and hence promote the activation of PI3K [14],
whereas mutation within the SH3 binding motif 1 of
NS1 is able to deprive NS1-p85b interaction and result
in the reduction of virulence of influenza A virus [15].
Apart from SH3, iSH2 domain (inter-SH2) and cSH2
domain (C-terminal SH2) domain of p85b are respon-
sible for NS1-p85b interaction and the subsequent
activation of PI3K [14,16,17]. NS1-mediated PI3K acti-
vation is obviously essential for influenza A virus repli-
cation because viral titers are significantly decreased
when PI3K is inhibited [18,19].
We hypothesized that viral replication could be
repressed by blocking NS1-p85b interaction (competi-
tively) with heterologously expressed SH3. Since pre-
vious studies have shown that NS1-mediated PI3K
activation is obviously important for the efficient propa-
gation of influenza A virus [7,14,18,20,21], in this study,
we examined the effect of heterologous SH3 (h-SH3) on
(i) the replicability of five strains of influenza A virus
from three subtypes (H1N1, H3N2, and H9N2) in
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Results
Co-localization of h-SH3 and NS1
Confocal microscopy was used to monitor the MDCK
cells transiently expressing h-SH3, NS1 (NS11, NS32, or
NS92), and co-expressing h-SH3 and NS1 (NS11, NS32,
or NS92). We found that h-SH3 mainly presented dif-
fused distribution within the nucleus and lesser within
the cytoplasm (Fig. 1A). And NS1 mainly presented dif-
fused distribution or some dot-like structures within the
nucleus (Fig. 1E). When co-expression, we found that h-
SH3 and NS1 mainly presented diffused distribution or
some dot-like structures within the nucleus (Fig. 1G and
1H), and h-SH3 located at the same position as NS1
which suggested the interaction between h-SH3 and
NS1 (Fig. 1I). Since NS1 from different influenza A
virus strains (NS11, NS32, or NS92) displayed the simi-
lar co-localized pattern with h-SH3 in MDCK cells, only
a representative figure was provided.
Differential suppressive effect of h-SH3 on the replication
kinetics of influenza A viruses
To examine if the replication of influenza A viruses
could be affected by h-SH3, we examined viral titers in
MDCK(SH3+) cells (MDCK cells transfected with SH3-
expressing plasmid) and control MDCK(SH3-) cells
(MDCK cells transfected with empty vector). Cells were
infected with a relatively low dose of influenza A viruses
(MOI = 0.001) and virus yield was determined by plaque
assay in MDCK cells. In comparison with the control,
the MDCK(SH3+) showed variable degrees of reduction
in viral titers at different time points (Fig. 2). The maxi-
mal reduction observed was about 8-fold with ST364,
about 6-fold with Qa199, about 4-fold with Ph2246, and
about 2-fold with ST1233 and PR8. These findings indi-
cate differential sensitivities of influenza A virus sub-
types/strains to h-SH3.
Differential suppressive effect of h-SH3 on the
phosphorylation status of Akt
As the h-SH3 had differential suppressive effect on the
replication of influenza A viruses, we further examined
the phosphorylation status of Akt (Akt-P) at Ser-473,
which is the marker commonly used to monitor the
activation state of PI3K [22], by measuring the ratio of
phosphorylated Akt (Akt-P)/total Akt (Akt-T) in virus-
infected MDCK(SH3+) and MDCK(SH3-) cells. Western
blot analysis showed that, compared to the uninfected
MDCK(SH3-) cells, the Akt-P level increased in PR8-,
ST364-, Ph2246-, or Qa199-infected MDCK(SH3-) cells
but not in ST1233-infected MDCK(SH3-) cells. More-
over, we observed the similar Akt-P and Akt-T levels in
MDCK(SH3+) and MDCK(SH3-) cells. In addition, we
found no change of Akt-P/Akt-T ratio in the ST1233-,
Ph2246-, or Qa199-infected MDCK(SH3+) cells, but sig-
nificant reduction of Akt-P/Akt-T ratio in the PR8- and
ST364-infected MDCK(SH3+) cells (Fig. 3). These data
suggested that in the absence of viral infection, h-SH3
had no effect on the phosphorylation of Akt and that
the suppressive effect of heterologous SH3 on the phos-
phorylation status of Akt was viral strain-specific.
Differential roles of PI3K in the replication of ST364 and
PR8 viruses
Having demonstrated the suppressive effect of h-SH3 on
the phosphorylation status of Akt in the ST364(H3N2)-
and PR8(H1N1)-infected cells, we further examined the
role of PI3K in the replication of these two viral strains
by treating them with the PI3K inhibitor, LY294002
(10 uM or 50 uM), followed by the plaque formation
assay. Significant reduction in the number of plaques was
observed in the ST364-infected cells, but there was no
obvious change with the PR8-infected cells. Treatment
with different concentrations (10 uM and 50 uM) of
LY294002 showed no obvious difference in replication.
Discussion
The binding of p85b subunit to the influenza A virus
NS1 protein results in the activation of PI3K/Akt path-
way, which in turn can promote the viral replication by
helping virus entry, viral RNA expression, nuclear
export of the RNPs, and preventing premature apoptosis
[19,23]. As NS1 interacts with p85b via direct binding
Figure 1 Confocal imaging of MDCK cells over-expressing SH3
and NS1. pSH3 (SH3-expressing plasmid based on a modified
pcDNA3 vector with the N-terminal Flag) and pNS1 (NS1-expressing
plasmid with the pEGFP-c1 backbone) were transiently transfected
into MDCK cells individually or together. 24 h post-transfection, cells
were stained with anti-Flag antibody and Cy3-labeled secondary
antibody. Detection of Cy3 channel seen as red (A, D, and G), GFP
channel seen as Green (B, E, and H), and Merged these two
channels (C, F, and I).
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to SH3, iSH2, or cSH2 domain of p85b, it can be specu-
lated that disturb this interaction by heterologously
expressed SH3, iSH2, or cSH2 may be a potential anti-
influenza strategy. Since iSH2 is also an interactive site
of p85b and p110 [16,17], overexpression of iSH2 may
interfere with the formation of PI3K in normal cells.
Additionally, given that the relative weak ability of cSH2
in mediating the interaction of p85b and NS1 [14], only
SH3 was thus chosen as a candidate antiviral agent in
this study. Our aim was to determine whether the SH3-
p85b site in the NS1 could be targeted by heterolo-
gously expressed SH3, thereby inhibiting influenza A
virus replication.
Subcellular localization in this study showed that in
MDCK cells transiently co-expressing NS11, NS32, or
NS92, the h-SH3 was colocalized with NS1 in the
nucleus (Fig. 1), implying the interaction of NS1 and
h-SH3. Combined with the results of Fig. 2, it can be
seen that in addition to its recognized interaction with
endogenous p85b subunit of PI3K via three binding
sites (SH3, iSH2, and cSH2) [14,16,17], NS1 can also
bind to heterologous SH3 and the interaction is strong
enough to result in suppression of viral replication,
though the degree of suppression was apparently differ-
ent among the viral strains.
As Akt-P is the major downstream product of acti-
vated PI3K, the Akt-P/Akt-T ratio was used to com-
pare the levels of virus-induced PI3K activation
affected by h-SH3 in cells infected with different influ-
enza A viruses. Remarkable elevation of Akt-P could
Figure 2 Replication kinetics of influenza A viruses in MDCK(SH3+) and control MDCK(SH3-) cells. Cells were infected with influenza A
viruses at an MOI of 0.001 and incubated with serum-free medium containing 1 ug/ml TPCK-trypsin. The yield of virus in the culture
supernatant was titrated every 12 h, from 12 h post-infection, by plaque assay in MDCK cells. The time point where maximal reduction was
observed is indicated with asterisk (*).
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be seen in PR8-, ST364-, Ph2246-, or Qa199-infected
cells, but not in ST1233-infected cells. In addition, h-
SH3 could reduce the PI3K activation in PR8- or
ST364-infected cells, while no alteration was observed
in ST1233-, Ph2246-, or Qa199-infected cells (Fig. 3).
The reason for this is unclear. As iSH2 domain may be
more important than SH3 for NS1-p85b interaction
[16,17], it is reasonable to speculate that for some
influenza A virus strains, h-SH3 could not be abso-
lutely essential for the activation of PI3K. Thus, even
through h-SH3 can disturb the NS1-p85b interaction,
its effect on the activation of PI3K and the ratio of
Akt-P/Akt-T may be negligible.
It has been shown that the PI3K/Akt pathway acti-
vated by NS1 is beneficial for influenza A virus infection
[22], and influenza A virus titers are significantly
decreased when PI3K is inhibited [18]. Interestingly, h-
SH3’s effect on PI3K/Akt pathway was not well corre-
lated with the replication of some viruses in this study.
While h-SH3 could inhibit replication of every strain of
influenza A virus to varying degrees, no suppression of
PI3K (or PI3K/Akt pathway) was observed in ST1233-,
Ph2246-, or Qa199-infected MDCK cells (Fig. 3). The
reason may involve the complicated relationship
between NS1 and cellular proteins. More than nine cel-
lular proteins were found directly interacted with NS1.
Among them, CPSF30 (30 kDa subunit of cleavage and
polyadenylation specificity factor) and p85b shared par-
tial overlapped binding sites (SH3 binding motif 1) in
NS1 [24]. Moreover, blocking the binding of endogen-
ous CPSF30 to NS1 protein can strikingly inhibit the
replication of influenza A virus [25]. Therefore, h-SH3
may also disrupt the interaction of NS1 and CPSF30
and then reduce the replication of some influenza A
viruses (such as ST1233, Ph2246, and Qa199) without
the reduction of Akt-P/Akt-T ratio.
Of note, the inhibitory effect of h-SH3 was stronger to
ST364 virus than PR8 virus. This finding is not consis-
tent with the similar reduction in the Akt-P/Akt-T ratio
in PR8-infected cells and ST364-infected cells. One pos-
sible explanation is that influenza A virus varied in their
sensitivity to PI3K/Akt pathway due to long-time evolu-
tion. And we found that compared to ST364 virus, PR8
virus was less susceptible to the treatment of LY294002
(PI3K inhibitor), which suggested that the activated
PI3K/Akt pathway is more important for ST364 replica-
tion than PR8 replication (Fig. 4).
Conclusions
In conclusion, this study demonstrates that h-SH3 can
inhibit the replication of influenza A viruses (H1N1,
H3N2, and H9N2) at different degrees, and targeting
NS1-p85b interaction (PI3K/Akt pathway) or other
virus-host interaction may be an attractive strategy
against the infection of various influenza A virus sub-
types/strains.
Methods
Cell lines, viruses, plasmids, and reagents
Madin-Darby canine kidney (MDCK) cell lines were
routinely cultured in Dulbecco’s modified Eagle’s med-
ium (DMEM) supplemented with 10% fetal calf serum
and antibiotics (100 U penicillin and 100 ug/ml strepto-
mycin) at 37℃ in 5% CO2.
Figure 3 Western blot analysis of phosphorylated Akt level in MDCK cells. MDCK cells with or without heterologous SH3 were infected
with PR8, ST1233, ST364, Ph2246, or Qa199 at an MOI of 2 for 8 h. Akt-P (phosphorylated Akt at Serine 473) and Akt-T (total Akt) in cellular
lysate were detected using anti-Akt-P and anti-Akt-T antibodies, respectively, and peroxidase-conjugated secondary antibody.
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Influenza A virus strains A/PR/8/34(H1N1), A/ST/
1233/2006(H1N1), A/ST/364/2005(H3N2), A/Ph/ST/
2246/2006(H9N2), and A/Qa/ST/199/2006(H9N2),
abbreviated herein to PR8, ST1233, ST364, Ph2246, and
Qa199, respectively, were used in this study.
SH3 domain (9-79aa) of p85b subunit was cloned into
PNF vector (a modified pcDNA3 plasmid with an N-term-
inal Flag tag) at the BamHI and EcoRI sites to generate
pSH3. Full-length NS1 sequence of H1N1, H3N2, or H9N2
viruses was cloned into pEGFP-c1 at the BamHI site to
generate pNS11, pNS32, or pNS92 plasmids, respectively.
The constructs were verified by DNA sequencing.
Rabbit monoclonal anti-phospho-Akt (Ser473) anti-
body were purchased from Cell Signaling Technology
(Danvers, MA, USA), Rabbit monoclonal anti-Flag anti-
body from Sigma (St. Louis, MO, USA), Rabbit mono-
clonal anti-Akt antibody, Cy3-labeled goat anti-rabbit
antibody, peroxidase-conjugated goat anti-rabbit anti-
body, and LY294002 (PI3K inhibitor) from Beyotime
Biotechnology (Jiangsu, China), and Lipofectamine 2000
from Invitrogen (Carlsbad, CA, USA).
Co-localization analysis by confocal microscopy
MDCK cell cultures on the glass coverslips were trans-
fected with indicated plasmids. 24 h post-transfection,
the cells were washed twice with phosphate-buffered sal-
ine (PBS), fixed for 10 min with 4% paraformaldehyde,
permeabilized with 0.2% Triton X-100 for 7 min, and
incubated for 30 min in PBS containing 3% Bovine
Serum Albumin (BSA). Cells were subsequently incu-
bated at room temperature with anti-Flag antibody (1/
500) for 2 h and Cy3-labeled secondary antibody (1/300)
for 1 h. Images were captured with the Olympus confo-
cal microscopy.
Transient transfection, viral infection, and determination
of antiviral activity
MDCK cells were seeded onto six-well plates and trans-
fected with pSH3 or PNF empty vector at 60% conflu-
ence as previously described [26]. After 48 h of
transfection, MDCK cells were infected with influenza
A viruses at a multiplicity of infection (MOI) of 0.001
in serum-free DMEM containing 1 ug/ml TPCK-trypsin
(Worthington, Freehold, NJ, USA) and incubated at 37°
C. An aliquot of the supernatant was harvested every 12
h and virus yield was titrated by plaque assay in MDCK
cells.
Western blot-based phosphorylation assay
MDCK cells transfected with indicated plasmids for 24 h
were infected with different influenza A virus strains at
an MOI of 2. At 8 h post infection the cells were lysed
with Laemmli sample buffer containing 5 mM of NaF
for 5 min in boiling water followed by brief sonication.
Protein concentration was determined using an RC-DC
kit (Bio-Rad, Hercules, CA, USA). Proteins (20 ug/lane)
were separated in 10% SDS-PAGE and transferred onto
a nitrocellulose membrane. The membrane was blocked
with Tris-buffered saline containing 0.1% Tween 20
(TBST) with 10% non-fat milk for 2 h and incubated
overnight at 4°C with anti-phospho-Akt (Ser473) (1/500)
or anti-Akt (1/700) antibody. The membrane was rinsed
extensively in TBST and incubated for 2 h with peroxi-
dase-conjugated secondary antibody (1/1000). Immuno-
blots were developed using the Enhanced
chemiluminescence (ECL) reagents (Pierce, Rockford, IL,
USA). Quantity One (Bio-Rad) software was used to
analyze images.
Determination of PI3K effect on the replication of ST364
and PR8 viruses
MDCK cells with 100% confluence were pretreated with
10 uM or 50 uM LY294002 (a specific PI3K inhibitor).
After 2 h, MDCK cells were infected with ST364 virus
or PR8 virus, and plaque assay was performed.
Figure 4 Differential roles of PI3K in replication of ST364(A)
and PR8(B) viruses. MDCK cells treated with LY294002 (10 uM) for
2 h and MDCK cells treated with DMSO (control) were infected with
ST364(H3N2) or PR8(H1N1) viruses and were subjected to the
plaque assay.
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